A critical appraisal of the clinical efficiency of anti-platelet drugs.
D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D004311:Double-Blind Method; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009204:Myocardial Revascularization; D011446:Prospective Studies; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013931:Thromboxanes / Q000378:metabolism
D013931:Thromboxanes; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone